CR
Capital Rx, Inc.
SEC filingOther · New York, NY
Amount raised$230.8Msold at filing
Total offering$232.9M$2.1M still open
Investors in the raise8count reported to the SEC
FiledSep 26, 2025first sale Aug 12, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jared J. KesselheimDirector
Mark J. KandrysawtzDirector
Lenard J. MarcusDirector
Ryan J. KellyDirector
Robert J. MittendorffDirector
Kevin J. HillDirector
Holly J. MaloneyDirector
Mostafa J. KamalDirector
A. J. LoiaconoExecutive Officer, Director
Daniel J. DelmastroDirector
Executive officers, directors and promoters as listed on the Form D.